Hemodialysis and Peritoneal Dialysis Market

Hemodialysis and Peritoneal Dialysis Market Size by Product (Machine, Bloodline, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (CAPD, Nocturnal), User (Hospital, Home Care) & Region - Global Forecast to 2029

Report Code: MD 2157 Apr, 2024, by marketsandmarkets.com

The size of global hemodialysis and peritoneal dialysis market in terms of revenue was estimated to be worth $92.0 billion in 2024 and is poised to reach $126.2 billion by 2029, growing at a CAGR of 6.5% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

The escalating global prevalence of chronic kidney disease, spurred by growing aging population coupled with the increasing cases of diabetes and hypertension are fuelling the demand for renal replacement therapy including hemodialysis and peritoneal dialysis products and services. Ongoing technological advancements in dialysis technology, growing patient preference of home dialysis, supporting reimbursement policies and government initiatives and funding for healthcare infrastructure, enabling expansion of hospitals and dialysis centers further enhancing the accessibility of hemodialysis and peritoneal dialysis services among patients with end-stage renal disease (ESRD) are likely to drive the market growth during the forecast period.

Attractive Opportunities Hemodialysis and Peritoneal Dialysis Market

Hemodialysis and Peritoneal Dialysis Market

To know about the assumptions considered for the study, Request for Free Sample Report

Hemodialysis and Peritoneal Dialysis Market

Hemodialysis and Peritoneal Dialysis Market Dynamics

Driver: Rising prevalence of chronic kidney disease globally

The rising prevalence of chronic kidney disease (CKD) globally is expected to significantly drive the hemodialysis and peritoneal dialysis market. Chronic kidney disease is likely to affect more than 10% of the population worldwide as chronic kidney disease becomes more prevalent due to factors such as aging populations, increasing rates of diabetes and hypertension, increasing the CKD progression to end-stage renal diseases, necessitating the dialysis. Chronic kidney disease (CKD) is more prevalent among individuals aged 65 years or older. According to Centres of Disease Control and Prevention (CDC), an estimated 35.5 million people in US were diagnosed with CKD in 2023.

Restraint: Complications linked with dialysis procedures

Dialysis, an essential renal replacement therapy for patients with end-stage renal disease, is associated with risks and complications. ESRD patients undergoing treatment are more susceptible to infections ranging from bloodstream infections to access site infections. Infectious and non-infectious vascular access complications are common and associated with increased morbidity, mortality, high costs, and reduced quality of life in dialysis patients. ESRD patients who choose HD require vascular access (catheters, grafts, and fistulae), and those who choose PD require a peritoneal catheter before initiation of RRT. The type of vascular access used in HD patients significantly influences patient survival due to associated complications. Compared with grafts and fistulae, catheters are associated with a substantially greater risk of sepsis, hospitalization, and mortality in HD patients. These associated risks and complications negatively affect the adoption of dialysis treatment among ESRD patients, thereby hampering the growth of the dialysis market.

Opportunity: High growth potential of emerging markets

Emerging markets such as China, India, Brazil, are expected to offer significant growth opportunities for players operating in the POC diagnostics market. This is primarily due to the high and growing prevalence of diabetes, chronic kidney diseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by BMC Nephrology in 2023, in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers.

Moreover, the rise in number of dialysis clinics in emerging countries can present a significant opportunity for hemodialysis and peritoneal dialysis market growth. Moreover initiatives undertaken by government to improve the access to healthcare services, including dialysis, across emerging nations through investment in healthcare infrastructure, subsidizing treatment costs are likely to enhance the market growth opportunities. Government of India has implemented Pradhan Mantri National Dialysis Programme (PMNDP) that offers free-of-cost dialysis services to Below Poverty Line (BPL) beneficiaries at district hospitals across the country. As of 31st December 2022, around 1.7 million beneficiaries availed of Haemodialysis and Peritoneal Dialysis services under PMNDP.

Challenge: Product Recall

The dialysis market has witnessed several recalls in the last few years due to health hazards related to their use and regulatory non-compliance. For instance

  • In 2023, Baxter Healthcare Corporation has recalled almost 280,000 bags of Dianeal peritoneal dialysis solution due to sterility concerns over potential leaks, according to the US Food and Drug Administration (FDA)
  • In 2023, Fresenius Medical Care recalled several hemodialysis machines for potential exposure to toxic compounds such as non-dioxin-like (NDL) polychlorinated biphenyl acids (PCBAs) that leak from some peroxide-cured silicone tubing used as part of the hydraulics in the machine and dialysate lines.

Recalls of dialysis devices place a significant financial burden on manufacturing firms due to costs to implement the recall, costs involved in product replacement, and the downturn in sales during a period of uncertainty. This, in turn, negatively affects the product scope, adoption, sales, growth prospects, and the capital structure of the manufacturing firm.

Market Ecosystem

Hemodialysis and Peritoneal Dialysis Market Ecosystem

The hemodialysis services to capture the largest market share of hemodialysis and peritoneal dialysis industry.

Based on the hemodialysis products and services market, the hemodialysis services segment holds the largest hemodialysis and peritoneal dialysis market share owing to growing number of ESRD patients and increasing utilization of hemodialysis treatment modality. Moreover, hemodialysis services are focusing on expanding their services offerings by launching and acquiring new dialysis centers across the globe. In January 2024, Diaverum, a Sweden based renal care service provider, acquired a network of six dialysis clinics across Greece, thus enhancing its customer base across the country.

By End User, home care settings to grow at a significant rate from 2024-2029 of hemodialysis and peritoneal dialysis industry.

Based on end users, home care setting is expected to grow at a significant rate owing to growing preference of patients for home hemodialysis modality, technological advancements, and the cost-effectiveness of home dialysis treatment over incentre dialysis procedures.

North America to account for the largest share of hemodialysis and peritoneal dialysis industry during the forecast period.

North America is expected to be the largest regional market for hemodialysis and peritoneal dialysis market during the forecast period. The presence of a well-established healthcare system, rapid increase in the availability of medical reimbursement for dialysis procedures, growing adoption of home-based dialysis modality, increasing prevalence of end-stage renal diseases across the nation, and strong geographical footprint of dialysis product manufacturers and service provider focusing on collaboration with renal care institutions are likely to support the hemodialysis and peritoneal dialysis market growth across the region.

Hemodialysis and Peritoneal Dialysis Market by Region

To know about the assumptions considered for the study, download the pdf brochure

As of 2023, prominent players in global hemodialysis and peritoneal dialysis market include Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Nipro Corporation (Japan), Diaverum (Germany), Medtronic plc (Ireland), Rockwell Medical, Inc. (US), Becton, Dickinson and Company (US), Dialife SA (Switzerland), and Isopure Corp. (US).

Scope of the Hemodialysis and Peritoneal Dialysis Industry

Report Metric

Details

Market Revenue Size in 2024

$92.0 billion

Projected Revenue Size by 2029

$126.2 billion

Industry Growth Rate

Poised to Grow at a CAGR of 6.5%

Market Driver

Rising prevalence of chronic kidney disease globally

Market Opportunity

High growth potential of emerging markets

This research report categorizes the hemodialysis and peritoneal dialysis market to forecast revenue and analyze trends in each of the following submarkets:

By Product and Services
  • By Hemodialysis Products
    • Hemodialysis Machines
      • Center-Use Hemodialysis Machines
      • Home-Use Hemodialysis Machines
    • Hemodialysis Consumables & Supplies
      • Dialyzers Market, By Material Type
        • Synthetic Dialyzers
        • Cellulose-Based Dialyzers
      • Dialyzers Market, By Flux Type
        • High-Flux Dialyzers
        • low Flux Dialyzers
      • Bloodlines Sets and tubes
      • Hemodialysis Concentrates/Dialysates
        • Alkaline Concentrates
        • Acidic Concentrates
      • Hemodialysis Access Products
        • AV Fistula Needles
        • Arteriovenous Grafts
        • Central Venous Catheters
      • Other Hemodialysis Consumables (endotoxin filters, bicarbonate cartridges, AV fistula needle and bags) -
    • Hemodialysis Services
  • Hemodialysis Market, by Modality
    • Conventional Hemodialysis
  • Short Daily Hemodialysis
    • Nocturnal Hemodialysis (NHD)
By Type
  • Central Water Disinfectant Systems
  • Portable Dialysis Water Disinfectant Systems
By Product and Services
  • Peritoneal Dialysis Products & services
    • Peritoneal Dialysis Concentrates/Dialysates
    • Peritoneal Dialysis Machines
    • Peritoneal Dialysis Catheters
    • Peritoneal Dialysis Transfer Sets
    • Other products (include PD accessories such as tubing sets, drain bags, disconnect caps, bag connections, catheter-stabilizing devices, and ports, among others) -
    • Peritoneal Dialysis Services
  • Peritoneal Dialysis Market, by Modality
    • Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • Ambulatory Peritoneal Dialysis (APD)
By Disease Indication
  • Acute Kidney Infections (AKI)
  • Chronic kidney disease (CKD) at end-stage OR End-Stage Renal Disease (ESRD
  • Other Indications (Severe electrolyte imbalances, fluid overload, and Poisoning)
By End User
  • Hospitals
  • Independent Dialysis Centers
  • Home Care Settings
  • Other Settings (Skilled Nursing Facilities, Rehabilitation Centers)
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoEU
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • Rest of the Middle East & Africa

Recent Developments of Hemodialysis and Peritoneal Dialysis Industry:

  • In July 2023, Rockwell Medical acquired the hemodialysis concentrates business from Evoqua Water Technologies, strengthening its presence in the hemodialysis market
  • In January 2022, Nextkidney BV acquired Dialyss Pte Ltd, enhancing its technology capabilities in home hemodialysis
  • In March 2021, DaVita Inc. signed an agreement with Fresenius Medical Care AG & Co. KGaA for the expansion of the usage of NxStage Home Hemodialysis Machines

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENT 
 
1 INTRODUCTION 
    1.1 OBJECTIVES OF THE STUDY  
    1.2 MARKET DEFINITION  
           1.2.1 KEY INCLUSIONS & EXCLUSIONS 
    1.3 RESEARCH SCOPE  
           1.3.1 SEGMENTS COVERED 
           1.3.2 GEOGRAPHIC SCOPE 
           1.3.3 YEARS CONSIDERED FOR THE STUDY 
    1.4 CURRENCY USED FOR THE STUDY  
    1.5 MAJOR MARKET STAKEHOLDERS  
    1.6 SUMMARY OF CHANGES  
           1.6.1 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY  
    2.1 RESEARCH DATA SOURCES 
           2.1.1 SECONDARY DATA 
           2.1.2 PRIMARY DATA
    2.2 MARKET SIZE ESTIMATION METHODOLOGY  
    2.3 MARKET SHARE ESTIMATION METHODOLOGY  
    2.4 MARKET BREAK DOWN AND DATA TRIANGULATION  
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS  
           2.6.1 SCOPE RELATED LIMITATIONS 
           2.6.2 METHODOLOGY RELATED LIMITATIONS
    2.7 RISK ASSESSMENT  
    2.8 RECESSION IMPACT ANALYSIS  
 
3 EXECUTIVE SUMMARY  
 
4 PREMIUM INSIGHTS  
    4.1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: MARKET OVERVIEW  
    4.2 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: BY PRODUCT AND SERVICES , 2023 VS 2029  
    4.3 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2023 VS 2029  
    4.4 GEOGRAPHIC ANALYSIS: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY AND REGION (2023) 
    4.5 GEOGRAPHIC SNAPSHOT OF THE POINT-OF-CARE DAIGNOSTICS MARKET  
 
5 MARKET OVERVIEW  
    5.1 MARKET DYNAMICS  
           5.1.1 MAJOR DRIVERS 
           5.1.2 KEY RESTRAINTS
           5.1.3 KEY GROWTH OPPORTUNITIES 
           5.1.4 INDUSTRY-SPECIFIC CHALLENGES 
    5.2 REGULATORY LANDSCAPE 
           5.2.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
           5.2.2 REGULATORY TRENDS
    5.3 VALUE CHAIN ANALYSIS 
    5.4 SUPPLY CHAIN ANALYSIS 
    5.5 ECOSYSTEM MARKET MAP 
    5.6 TECHNOLOGY ANALYSIS  
           5.6.1 KEY TECHNOLOGIES 
           5.6.2 COMPLEMENTARY TECHNOLOGIES 
           5.6.3 ADJACENT TECHNOLOGIES 
    5.7 TRADE ANALYSIS 
    5.8 PATENT ANALYSIS  
           5.8.1 PATENT PUBLICATION TRENDS FOR THE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
           5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    5.9 PORTER’S FIVE FORCE ANALYSIS 
    5.10 PRICING ANALYSIS 
           5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
           5.10.2 AVERAGE SELLING PRICE TREND, BY REGION
    5.10 KEY CONFERENCES & EVENTS DURING 2024-2025 
    5.11 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.11.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
           5.11.2 BUYING CRITERIA
    5.12 REIMBURSEMENT ANALYSIS  
 
6 HEMODIALYSIS MARKET, BY PRODUCT AND SERVICES (USD MILLION; 2022—2029)*  
    6.1 INTRODUCTION 
    6.2 HEMODIALYSIS MARKET , BY PRODUCTS AND SERVICES  
           6.2.1 HEMODIALYSIS MACHINES 
                    6.2.1.1 CENTER-USE HEMODIALYSIS MACHINES
                    6.2.1.1 HOME-USE HEMODIALYSIS MACHINES
           6.2.2 HEMODIALYSIS CONSUMABLES AND SUPPLIES 
                    6.2.2.1 DIALYZERS 
                               6.2.2.1.1 DIALYZERS MARKET , BY MATERIAL 
                                             6.2.2.1.1.1 SYNTHETIC DIALYZERS 
                                             6.2.2.1.1.2 CELLUSOSE BASED DIALYZERS 
                               6.2.2.1.2 DIALYZERS MARKET , BY FLUX 
                                             6.2.2.1.2.1 HIGH FLUX DIALYZERS
                                             6.2.2.1.2.2 LOW FLUX DIALYZERS .
                    6.2.2.2 BLOODLINES SETS AND TUBES 
                    6.2.2.3 HEMODIALAYSIS CONCENTRATES/DIALYSATES
                               6.2.2.3.1 ALKALINE CONCENTRATES/DIALYSATES
                               6.2.2.3.2 ACIDIC CONCENTRATES/DIALYSATES
                    6.2.2.4 OTHER HEMODIALYSIS CONSUMABLES (ENDOTOXIN FILTERS, BICARBONATE CARTRIDGES, AV FISTULA NEEDLE AND BAGS)
           6.2.3 HEMODIALYSIS SERVICES 
    6.3 HEMODIALYSIS MARKET BY MODALITY  
           6.3.1 CONVENTIONAL HEMODIALYSIS 
           6.3.2 SHORT DAILY HEMODIALYSIS 
           6.3.2 NOCTURNAL HEMODIALYSIS (NHD) 
    6.4 HEMODIALAYIS WATER TREATMENT SYSTEMS MARKET, BY TYPE 
           6.4.1 CENTRAL WATER DISINFECTANT SYSTEMS
           6.4.2 PORTABLE DIALYSIS WATER DISINFECTANT SYSTEMS
 
7 PERITONEAL DIALYSIS MARKET, BY PRODUCT AND SERVICES (USD MILLION; 2022—2029)*  
    7.1 INTRODUCTION 
    7.2 PERITONEAL DIALYSIS MARKET , BY PRODUCTS AND SERVICES 
           7.2.1 PERITONEAL DIALYSIS MACHINES
           7.2.2 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES 
           7.2.3 PERITONEAL DIALYSIS CATHETERS
           7.2.4 PERITONEAL DIALYSIS TRANSFER SETS
           7.2.5 OTHER PD PRODUCTS (INCLUDE PD ACCESSORIES SUCH AS TUBING SETS, DRAINAGE BAGS, DIALAYIS SOLUTION BAGS, DISCONNECT CAPS, BAG CONNECTORS, FLOW REGULATORS, AMONG OTHERS)
           7.2.3 PERITONEAL DIALYSIS SERVICES
    7.3 PERITONEAL DIALYSIS MARKET , BY MODALITY  
           7.3.1 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD)
           7.3.2 AUTOMATED PERITONEAL DIALYSIS (APD)
 
8 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DISEASE INDICTION (USD MILLION; 2022—2029)*  
    8.1 INTRODUCTION  
    8.2 ACUTE KIDNEY INJURY (AKI) 
    8.3 CHRONIC KIDNEY DISEASE (CKD) AT END-STAGE.OR END-STAGE RENAL DISEASE (ESRD). 
    8.4 OTHER INDICATIONS (SEVERE ELECTROLYTE IMBALANCES, FLUID OVERLOAD, AND POISONING) 
 
9 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER (USD MILLION; 2022—2029)*  
    9.1 INTRODUCTION  
    9.2 HOSPITALS 
    9.3 INDEPENDENT DIALYSIS CENTRES  
    9.4 HOME CARE SETTINGS   
    9.5 OTHER SETTINGS (SKILLED NURSING FACILITIES (SNFS), HEALTHCARE REHABILITATION CENTERS)  
 
10 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION (USD MILLION; 2022—2029)*  
     10.1 NORTH AMERICA 
             10.1.1 RECESSION IMPACT
             10.1.2 US
             10.1.3 CANADA
     10.2 EUROPE  
             10.2.1 RECESSION IMPACT
             10.2.2 GERMANY
             10.2.3 UK
             10.2.4 FRANCE
             10.2.5 ITALY 
             10.2.6 SPAIN 
             10.2.7 REST OF EUROPE
     10.3 ASIA-PACIFIC 
             10.3.1 RECESSION IMPACT 
             10.3.2 JAPAN 
             10.3.3 CHINA 
             10.3.4 INDIA 
             10.3.5 SOUTH KOREA 
             10.3.6 AUSTRALIA 
             10.3.7 REST OF ASIA-PACIFIC
     10.4 LATIN AMERICA 
             10.4.1 RECESSION IMPACT
             10.4.2 BRAZIL
             10.4.3 MEXICO
             10.4.4 REST OF LATIN AMERICA 
     10.5 MIDDLE EAST AND AFRICA  
             10.5.1 RECESSION IMPACT
             10.5.2 GCC COUNTRIES 
             10.5.3 REST OF MIDDLE EAST & AFRICA
 
11  COMPETITIVE LANDSCAPE  
     11.1 OVERVIEW  
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
     11.3 REVENUE MAPPNG OF TOP PLAYERS (2023)  
     11.4 MARKET SHARE ANALYSIS FOR TOP 5 GLOBAL PLAYERS (IN TERMS OF % REVENUE, IN 2023)  
     11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023  
             11.5.1 STARS 
             11.5.2 EMERGING LEADERS .
             11.5.3 PERVASIVE PLAYERS . 
             11.5.4 PARTICIPANTS 
             11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023  
                        11.5.5.1 COMPANY FOOTPRINT 
                        11.5.5.2 REGION FOOTPRINT .
                        11.5.5.3 PRODUCT FOOTPRINT
                        11.5.5.4 SERVICE FOOTPRINT
                        11.5.5.5 END USER FOOTPRINT
     11.6 COMPANY EVALUATION MATRIX:STARTUP/SME EVALUATION MATRIX, 2023 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 RESPONSIVE COMPANIES
             11.6.3 DYNAMIC COMPANIES
             11.6.4 STARTING BLOCKS
             11.6.5 COMPETITIVE BENCHMARKING STARTUPS/SMES,2023
                        11.6.5.1 DETAILED LIST OF KEY STARTUPS/SMEs
                        11.6.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMEs
     11.7 COMPETITIVE SCENARIO AND TRENDS (2021-2024)  
             11.7.1 PRODUCT LAUNCHES
             11.7.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
             11.7.3 MERGERS AND ACQUISITIONS
             11.7.4 EXPANSIONS
     11.8 INVESTMENT AND FUNDING SCENARIO  
     11.9 PRODUCT COMPARITIVE ANALYSIS  
 
12 COMPANY PROFILES** 
(Business Overview, Products Offered, Industry-specific Developments for 2021-2023)***
     12.1 KEY COMPANIES  
             12.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA 
             12.1.2 BAXTER. 
             12.1.3 B. BRAUN .
             12.1.4 DAVITA INC.
             12.1.5 ASAHI KASEI MEDICAL CO., LTD. 
             12.1.6 BECTON, DICKINSON AND COMPANY .
             12.1.7 NIPRO CORPORATION .
             12.1.8 NIKKISO CO., LTD.
             12.1.9 DIAVERUM 
             12.1.10 MEDTRONIC 
             12.1.11 ROCKWELL MEDICAL, INC. .
             12.1.12 AMERIWATER LLC
             12.1.13 ISOPURE CORP
             12.1.14 DIALIFE GROUP .
             12.1.15 TORAY MEDICAL CO., LTD
             12.1.16 JMS CO., LTD .
             12.1.17 ATLANTIC BIOMEDICAL 
             12.1.18 TERUMO CORPORATION. 
             12.1.19 MERIT MEDICAL SYSTEMS.
             12.1.20 COOK MEDICAL
     12.2 OTHER PLAYERS  
             12.2.1 OUTSET MEDICAL 
             12.2.2 QUANTA DIALYSIS TECHNOLOGIES LTD
             12.2.3 U.S. RENAL CARE, INC.
             12.2.4 POLY MEDICURE LTD.
             12.2.5 INNAVASC MEDICAL, INC 
             12.2.6 AMECATH MEDICAL TECHNOLOGIES
             12.2.7 XYLEM. 
             12.2.8 ALLMED MEDICAL CARE HOLDINGS LIMITED. 
             12.2.9 SHENZHEN LANDWIND BIOMEDICAL TECHNOLOGY CO., LTD 
 
13 APPENDIX 
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 AVAILABLE CUSTOMIZATIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 
 
*The segmentation of the study can be updated during the course of the study based on primary insights and secondary research
*The list of companies mentioned above is indicative only and might change during the course of the study.
*Details on key financials might not be captured in the case of unlisted companies.

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), American Society Nephrology (ASN), American Association of Kidney Patients (AAKP), European Renal Association (ERA) were referred to identify and collect information for the global hemodialysis and peritoneal dialysis market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the hemodialysis and peritoneal dialysis market. The primary sources from the demand side include hospitals, outpatient dialysis centers, home care setting among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Hemodialysis and Peritoneal Dialysis Market Size, and Share

*C-level primaries include CEOs, CFOs, COOs, and VPs.

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2022, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global hemodialysis and peritoneal dialysis market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players (who contribute at least 85–90% of the market share at the global level). Also, the global hemodialysis and peritoneal dialysis market was split into various segments and sub-segments based on:

  • list of major players operating in the hemodialysis and peritoneal dialysis products and services market at the regional and/or country level
  • Product mapping of various hemodialysis and Peritoneal dialysis manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from dialysis (or the nearest reported business unit/product category)
  • Revenue mapping of major players to cover at least 65-70% of the global market share as of 2023
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global hemodialysis and peritoneal dialysis market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Market Size Estimation: Hemodialysis And Peritoneal Dialysis Market Based On Revenue Mapping Methodology

Hemodialysis and Peritoneal Dialysis Market Size, and Share

Data Triangulation

After arriving at the overall size of the global Hemodialysis and peritoneal dialysis market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Dialysis refers to a medical procedure essential individual suffering from chronic kidney diseases or impaired kidney function. It involves the removal of waste products and excess fluids from the blood, a function the kidneys normally perform. Dialysis can be of two main types: hemodialysis, where blood is filtered through a machine acting as an artificial kidney, and peritoneal dialysis, which uses the lining of the abdomen as a natural filter. By balancing electrolytes and fluid levels in the body.

Key Market Stakeholders

  • Hemodialysis and Peritoneal Dialysis Product Manufacturers
  • Hemodialysis and Peritoneal Dialysis Services Providers
  • Distributors, Channel Partners, and Third-party Suppliers
  • Hospitals, Independent Dialysis Centers, skilled Nursing Facilities
  • Nephrologist
  • Dialysis Nurses
  • R&D Companies
  • Business Research and Consulting Service Providers

Report Objectives

  • To define, describe, and forecast the global hemodialysis and peritoneal dialysis market on the basis of hemodialysis and peritoneal dialysis product and Services, disease indication, end user and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for major market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa
  • To profile the key market players and comprehensively analyze their market shares and core competencies2
  • To track and analyze competitive developments such as mergers and acquisitions, new product developments, partnerships, agreements, collaborations, and expansions in the global hemodialysis and peritoneal dialysis market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the global hemodialysis and peritoneal dialysis market report.

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five global players.

Company Information

  • Detailed analysis and profiling of additional market players (up to 5 OEMs)

Geographic Analysis

  • Further breakdown of the Rest of Europe hemodialysis and peritoneal dialysis market into Belgium, Austria, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among other
  • Further breakdown of the Rest of Asia Pacific hemodialysis and peritoneal dialysis market into New Zealand, Vietnam, Philippines, Singapore, Malaysia, Thailand, and Indonesia, among other countries
  • Further breakdown of the Rest of Latin America hemodialysis and peritoneal dialysis market into Argentina, and Colombia, among other countries.
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 2157
Published ON
Apr, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Hemodialysis and Peritoneal Dialysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback